Martinez-Martin Pablo, Wetmore John B, Rodríguez-Blázquez Carmen, Arakaki Tomoko, Bernal Oscar, Campos-Arillo Victor, Cerda Christopher, Estrada-Bellmann Ingrid, Garretto Nélida, Ginsburg Letty, Máñez-Miró Jorge Uriel, Martínez-Castrillo Juan Carlos, Pedroso Ivonne, Serrano-Dueñas Marcos, Singer Carlos, Rodríguez-Violante Mayela, Vivancos Francisco
National Center of Epidemiology Carlos III Institute of Health Madrid Spain.
Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED) Carlos III Institute of Health Madrid Spain.
Mov Disord Clin Pract. 2019 Mar 18;6(4):294-301. doi: 10.1002/mdc3.12749. eCollection 2019 Apr.
Because of the prevalence and impact of sleep disorders in Parkinson's disease (PD), valid instruments for their evaluation and monitoring are necessary. However, some nocturnal sleep disorders may go unnoticed by patients themselves.
To validate a pan-Spanish version of the Parkinson's Disease Sleep Scale Version 2 (PDSS-2) and to test the relationships between the PDSS-2 and a PDSS-2 roommate version.
PD patients (n = 399) from seven Spanish-speaking countries were included. In addition to the tested PDSS-2 scales, valid measures for sleep disorders and both motor and nonmotor manifestations were applied. Acceptability, dimensionality, reliability, precision, and construct validity were explored, as well as discrepancies and agreement between the PDSS-2 and the roommate version.
PDSS-2 showed negligible floor and ceiling effects. Four factors (57% of the variance) were identified. Reliability parameters were satisfactory: alpha = 0.84; item homogeneity coefficient = 0.27; corrected item total correlation = 0.28 to 0.61; and test-retest reliability (average kappa = 0.70; intraclass correlation coefficient [ICC] = 0.83). The standard error of measurement was 5.84, and correlations with other scales assessing nocturnal sleep were high (r = 0.62-0.56). In comparison to the patient-based total score, the by proxy total score showed no significant difference, high correlation (r = 0.70), and acceptable agreement (ICC = 0.69), but there were discrepancies in two or more points in 18% of item scores.
The Spanish version of the PDSS-2 has shown satisfactory clinimetric attributes. Acceptability and precision data are presented for the first time. The PDSS-2 roommate version could be useful to complement the patient-based evaluation, but additional studies are needed.
由于帕金森病(PD)中睡眠障碍的普遍性和影响,需要有效的评估和监测工具。然而,一些夜间睡眠障碍可能患者自身并未察觉。
验证帕金森病睡眠量表第2版(PDSS - 2)的泛西班牙语版本,并测试PDSS - 2与PDSS - 2室友版本之间的关系。
纳入来自七个讲西班牙语国家的PD患者(n = 399)。除了测试的PDSS - 2量表外,还应用了睡眠障碍以及运动和非运动表现的有效测量方法。探讨了可接受性、维度性、可靠性、精确性和结构效度,以及PDSS - 2与室友版本之间的差异和一致性。
PDSS - 2显示地板效应和天花板效应可忽略不计。识别出四个因素(方差的57%)。可靠性参数令人满意:α = 0.84;项目同质性系数 = 0.27;校正后的项目总分相关性 = 0.28至0.61;重测信度(平均kappa = 0.70;组内相关系数[ICC] = 0.83)。测量的标准误差为5.84,与其他评估夜间睡眠的量表的相关性较高(r = 0.62 - 0.56)。与基于患者的总分相比,代理总分无显著差异,相关性高(r = 0.70),一致性可接受(ICC = 0.69),但18%的项目得分存在两点或更多点的差异。
PDSS - 2的西班牙语版本显示出令人满意的临床测量属性。首次呈现了可接受性和精确性数据。PDSS - 2室友版本可能有助于补充基于患者的评估,但还需要更多研究。